General Information of Disease (ID: DISRMNLQ)

Disease Name Dubowitz syndrome
Synonyms
intrauterine growth retardation, short stature, microcephaly, mild mental retardation with behavior problems, eczema, and unusual and distinctive faci; dwarfism-eczema-peculiar facies syndrome; intrauterine growth retardation, short stature, microcephaly, mild mental retardation with behaviour problems, eczema, and unusual and distinctive faci; intrauterine growth retardation, short stature, microcephaly, mild intellectual disability with behavior problems, eczema, and unusual and distinctive faci; intrauterine growth retardation, short stature, microcephaly, mild intellectual disability with behaviour problems, eczema, and unusual and distinctive faci; Dubowitz syndrome; Dubowitz's syndrome
Definition
A rare multiple congenital syndrome characterized primarly by growth retardation, microcephaly, distinctive facial dysmorphism, cutaneous eczema, a mild to severe intellectual deficit and genital abnormalities.
Disease Hierarchy
DISLRS4M: Ectodermal dysplasia
DISDOXWZ: Multiple congenital anomalies/dysmorphic syndrome-intellectual disability
DISRMNLQ: Dubowitz syndrome
Disease Identifiers
MONDO ID
MONDO_0009124
MESH ID
C535718
UMLS CUI
C0175691
OMIM ID
223370
MedGen ID
59797
Orphanet ID
235
SNOMED CT ID
2593002

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 2 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
PTPN11 TT7WUAV Strong Biomarker [1]
RAF1 TTAN5W2 Strong Biomarker [2]
------------------------------------------------------------------------------------
This Disease Is Related to 6 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
LIG4 OT40DNXU Supportive Autosomal recessive [3]
NSUN2 OTZCNM33 Supportive Autosomal recessive [4]
LZTR1 OTIDM6XO Strong Biomarker [5]
PLXNA1 OTN0BING Strong Genetic Variation [6]
RIT1 OTVNOGOH Strong Biomarker [7]
SOS1 OTTCWXC3 Strong Biomarker [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 DOT(s)

References

1 Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.Nat Med. 2004 Aug;10(8):849-57. doi: 10.1038/nm1084. Epub 2004 Jul 25.
2 Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutants.Mol Cell Biol. 2012 Oct;32(19):3872-90. doi: 10.1128/MCB.00751-12. Epub 2012 Jul 23.
3 Dubowitz syndrome is a complex comprised of multiple, genetically distinct and phenotypically overlapping disorders. PLoS One. 2014 Jun 3;9(6):e98686. doi: 10.1371/journal.pone.0098686. eCollection 2014.
4 Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome. J Med Genet. 2012 Jun;49(6):380-5. doi: 10.1136/jmedgenet-2011-100686. Epub 2012 May 10.
5 Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination.Science. 2018 Dec 7;362(6419):1177-1182. doi: 10.1126/science.aap7607. Epub 2018 Nov 15.
6 PLXNA1 developmental encephalopathy with syndromic features: A case report and review of the literature.Am J Med Genet A. 2017 Jul;173(7):1951-1954. doi: 10.1002/ajmg.a.38236. Epub 2017 May 2.
7 New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to -adrenergic stimulation-induced cardiac fibrosis.EBioMedicine. 2019 Apr;42:43-53. doi: 10.1016/j.ebiom.2019.03.014. Epub 2019 Mar 18.
8 Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndromeassociated Sos1 mutation.J Clin Invest. 2010 Dec;120(12):4353-65. doi: 10.1172/JCI43910.